http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24205519

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage S27
issn 0960-9776
pageRange S20-S27
publicationName Breast (Edinburgh, Scotland)
startingPage S20
bibliographicCitation Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart M. Beyond trastuzumab: new treatment options for HER2-positive breast cancer. Breast. 2011 Oct;20 Suppl 3():S20–7. doi: 10.1016/s0960-9776(11)70289-2. PMID: 22015288.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6137-9171
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e740fc944f9695dff1e1494d9ab0706c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee62b9a99d571b45de886e6e57111b85
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6301-3309
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53f877f5e74aac75168abbee35cfb272
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a9e7cb1da8277359e4ce6ceab1aa82d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63131793c70cd04fd38fd82de7782ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39f17768ab14856aef540cb8bb0893cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c20c5d8d8ba117ffc8a74d166725b733
date 201110
identifier https://pubmed.ncbi.nlm.nih.gov/22015288
https://doi.org/10.1016/s0960-9776%2811%2970289-2
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31740
https://portal.issn.org/resource/ISSN/0960-9776
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Beyond trastuzumab: New treatment options for HER2-positive breast cancer
discusses http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0543872
http://id.nlm.nih.gov/mesh/M0291428
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0473129
http://id.nlm.nih.gov/mesh/M0466011
http://id.nlm.nih.gov/mesh/M0018350
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000401
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D018719Q000037
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D058990Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D018719Q000235
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D011804Q000627
http://id.nlm.nih.gov/mesh/D018570
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D047428Q000009
http://id.nlm.nih.gov/mesh/D001943Q000601
http://id.nlm.nih.gov/mesh/D001943Q000378
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D020360
http://id.nlm.nih.gov/mesh/D000068878
http://id.nlm.nih.gov/mesh/D000077341
http://id.nlm.nih.gov/mesh/D011799Q000627
http://id.nlm.nih.gov/mesh/D019008
http://id.nlm.nih.gov/mesh/D017322
http://id.nlm.nih.gov/mesh/D061067Q000627
http://id.nlm.nih.gov/mesh/D018719Q000378
http://id.nlm.nih.gov/mesh/D017024
http://id.nlm.nih.gov/mesh/D001530
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9915743
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6505803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cae1136973304226b6579fdacf6db996

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246842401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245740308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626

Total number of triples: 78.